Xueying Chen
Research Subjects
Xueying Chen has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Bing Yu
Department of Epidemiology, School of Public Health, The University of Texas Health Science Center at Houston , 1200 Pressler St, Houston, TX, 77030
2 shared publications- Dmitry Prokopenko
Genetics and Aging Research Unit and the McCance Center for Brain Health, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA
2 shared publications Eric Boerwinkle
Department of Epidemiology, School of Public Health, The University of Texas Health Science Center at Houston , 1200 Pressler St, Houston, TX, 77030
2 shared publications- Harry Benjamin Larman
Institute for Cell Engineering, Division of Immunology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
2 shared publications - Jessica Lasky-Su
Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, USA
2 shared publications - Julian Hecker
Channing Division of Network Medicine, Mass General Brigham and Harvard Medical School, Boston, MA, USA
2 shared publications
Latest Publications
- Open Access
- 20 November 2026
- Published by Springer Nature in Nature Immunology
Large-scale antibody reactome profiling identifies herpesvirus–autoantigen associations that underlie chronic diseases
- 20 November 2026
- Published by Springer Nature in Nature Immunology
Open AccessLarge-scale antibody reactome profiling identifies herpesvirus–autoantigen associations that underlie chronic diseases
- Open Access
- 25 September 2026
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 35 (20)
Explaining the unexplained admixture mapping signals via rare variants: the HCHS/SOL
In admixed populations, formed by a mixing of two or more previously isolated populations, genomic segments can be traced to their ancestral populations (‘ancestries’). Admixture mapping (AM) associates local ancestry with outcomes in admixed populations, detecting signals when causal variants differ in frequency or effect across ancestral populations. Prior work showed that adjusting for nearby GWAS-identified common variants does not fully explain some AM signals. Here, we assessed two approaches to explain the previously unexplained AM signal: (1) including sets of rare variants; (2) increasing the genomic region considered when searching for common variants. We studied these hypotheses comprehensively using a whole-genome sequencing dataset coupled with metabolomics from the Hispanic Community Health Study/Study of Latinos. From 16 genomic regions of interest, we identified 35 rare-variant sets associated with metabolite levels, of which 4 associations replicated. The locations of identified rare variant sets are either within the same gene or in proximity to adjusted common variants. Overall, our study provides new insight into the genetic architecture underlying AM signals via evaluating the contributions of common and rare variant sets. By integrating rare-variant analysis within the AM framework, our work highlights the potential interplay between variant types and establishes a novel strategy to guide future fine-mapping and causal variant identification in admixed populations. Yet the detected rare variants appear to explain only a small fraction of the AM signal, while inclusion of common variants from a larger genomic region appears to explain most of the AM signals.
- 25 September 2026
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 35 (20)
Open AccessExplaining the unexplained admixture mapping signals via rare variants: the HCHS/SOL
In admixed populations, formed by a mixing of two or more previously isolated populations, genomic segments can be traced to their ancestral populations (‘ancestries’). Admixture mapping (AM) associates local ancestry with outcomes in admixed populations, detecting signals when causal variants differ in frequency or effect across ancestral populations. Prior work showed that adjusting for nearby GWAS-identified common variants does not fully explain some AM signals. Here, we assessed two approaches to explain the previously unexplained AM signal: (1) including sets of rare variants; (2) increasing the genomic region considered when searching for common variants. We studied these hypotheses comprehensively using a whole-genome sequencing dataset coupled with metabolomics from the Hispanic Community Health Study/Study of Latinos. From 16 genomic regions of interest, we identified 35 rare-variant sets associated with metabolite levels, of which 4 associations replicated. The locations of identified rare variant sets are either within the same gene or in proximity to adjusted common variants. Overall, our study provides new insight into the genetic architecture underlying AM signals via evaluating the contributions of common and rare variant sets. By integrating rare-variant analysis within the AM framework, our work highlights the potential interplay between variant types and establishes a novel strategy to guide future fine-mapping and causal variant identification in admixed populations. Yet the detected rare variants appear to explain only a small fraction of the AM signal, while inclusion of common variants from a larger genomic region appears to explain most of the AM signals.
- Open Access
- 13 April 2026
- Published by Springer Nature in Research Square
Large-scale antibody reactome profiling identifies herpesvirus-autoantigen associations underlying chronic diseases
Herpesviruses infect nearly all humans and have long been implicated in autoimmune and chronic diseases, yet their immune interactions with host proteins have not been systematically characterized at population scale. We profiled immunoglobulin G reactivities to >4,600 herpesvirus peptides and >15,000 human proteins using multiplexed protein display in two Mass General Brigham Biobank cohorts (discovery n=1,289; replication n=763), with longitudinal electronic health record follow-up. We identified and replicated 3,943 FDR-significant associations across 93 autoantigens, including previously uncharacterized viral–autoantigen axes, such as PHLDA1 and ZNF550. Eleven autoantigens were predicted by viral peptide reactivities with >85% accuracy in independent validation; some exhibited shared viral–host sequence homology, consistent with possible molecular mimicry. Integrating immune reactivities with incident disease outcomes revealed virus-specific network architectures: cytomegalovirus formed the largest multimorbid network, Epstein–Barr virus converged on pleiotropic autoimmune hubs, and herpes simplex viruses formed smaller, partially overlapping autoreactive networks. These findings define a herpesvirus–autoantigen–disease network atlas and prioritize candidate viral–host immune axes for mechanistic investigation.
- 13 April 2026
- Published by Springer Nature in Research Square
Open AccessLarge-scale antibody reactome profiling identifies herpesvirus-autoantigen associations underlying chronic diseases
Herpesviruses infect nearly all humans and have long been implicated in autoimmune and chronic diseases, yet their immune interactions with host proteins have not been systematically characterized at population scale. We profiled immunoglobulin G reactivities to >4,600 herpesvirus peptides and >15,000 human proteins using multiplexed protein display in two Mass General Brigham Biobank cohorts (discovery n=1,289; replication n=763), with longitudinal electronic health record follow-up. We identified and replicated 3,943 FDR-significant associations across 93 autoantigens, including previously uncharacterized viral–autoantigen axes, such as PHLDA1 and ZNF550. Eleven autoantigens were predicted by viral peptide reactivities with >85% accuracy in independent validation; some exhibited shared viral–host sequence homology, consistent with possible molecular mimicry. Integrating immune reactivities with incident disease outcomes revealed virus-specific network architectures: cytomegalovirus formed the largest multimorbid network, Epstein–Barr virus converged on pleiotropic autoimmune hubs, and herpes simplex viruses formed smaller, partially overlapping autoreactive networks. These findings define a herpesvirus–autoantigen–disease network atlas and prioritize candidate viral–host immune axes for mechanistic investigation.
- 7 March 2026
- Published by Wiley in New Phytologist
- Vol. 250 (4) , 2586-2598
Functional uncoupling of the induced defense‐competitive growth trade‐off
Summary: Trade‐offs between induced plant defenses and competitive growth are regarded as being universal. This seems particularly true for often‐studied early succession annuals, where exposure to competition often suppresses defense expression. However, whether such trade‐offs are universal across plant life histories remains unclear, especially considering recent work demonstrating that the trade‐off can be artificially uncoupled. We test the hypothesis that Solidago altissima , a perennial herbaceous plant, naturally uncouples this trade‐off by adjusting its investment in chemical defenses when exposed to competitive cues, allowing for persistence in high‐competition environments despite herbivore pressure. Using a factorial glasshouse experiment, we manipulated competition cues (far‐red light and conspecific neighbors) and insect herbivory to assess impacts on growth, resistance, and secondary metabolite production. S. altissima maintained or even enhanced herbivore‐induced resistance in the presence of competition cues. Bioassays revealed reduced herbivore performance on previously damaged plants, particularly when they were exposed to neighbors. Metabolomic profiling showed herbivory‐induced production of several secondary metabolite classes. Most notably, we found competition‐enhanced production of hydroxycinnamic acids, dominated by 3‐O‐( E )‐feruloylquinic acid, associated with resistance. Our findings challenge the generality of the growth‐defense trade‐off and highlight the importance of ecological context and life‐history strategy in shaping plastic responses.
- 7 March 2026
- Published by Wiley in New Phytologist
- Vol. 250 (4) , 2586-2598
Functional uncoupling of the induced defense‐competitive growth trade‐off
Summary: Trade‐offs between induced plant defenses and competitive growth are regarded as being universal. This seems particularly true for often‐studied early succession annuals, where exposure to competition often suppresses defense expression. However, whether such trade‐offs are universal across plant life histories remains unclear, especially considering recent work demonstrating that the trade‐off can be artificially uncoupled. We test the hypothesis that Solidago altissima , a perennial herbaceous plant, naturally uncouples this trade‐off by adjusting its investment in chemical defenses when exposed to competitive cues, allowing for persistence in high‐competition environments despite herbivore pressure. Using a factorial glasshouse experiment, we manipulated competition cues (far‐red light and conspecific neighbors) and insect herbivory to assess impacts on growth, resistance, and secondary metabolite production. S. altissima maintained or even enhanced herbivore‐induced resistance in the presence of competition cues. Bioassays revealed reduced herbivore performance on previously damaged plants, particularly when they were exposed to neighbors. Metabolomic profiling showed herbivory‐induced production of several secondary metabolite classes. Most notably, we found competition‐enhanced production of hydroxycinnamic acids, dominated by 3‐O‐( E )‐feruloylquinic acid, associated with resistance. Our findings challenge the generality of the growth‐defense trade‐off and highlight the importance of ecological context and life‐history strategy in shaping plastic responses.
- Open Access
Explaining the unexplained admixture mapping signals via rare variants: the HCHS/SOL
In admixed populations, formed by a mixing of two or more previously isolated populations, genomic segments can be traced to their ancestral populations (“ancestries”). Admixture mapping (AM) associates local ancestry with outcomes in admixed populations, detecting signals when causal variants differ in frequency or effect across ancestral populations. Prior work showed that adjusting for nearby GWAS-identified common variants does not fully explain some AM signals. Here, we assessed two approaches to explain the previously unexplained AM signal: (1) including sets of rare variants; (2) increasing the genomic region considered when searching for common variants. We studied these hypotheses comprehensively using a whole-genome sequencing dataset coupled with metabolomics from the Hispanic Community Health Study/Study of Latinos. We detected multiple sets of rare variants with replicated association with metabolite levels. Yet these rare variants appear to explain only a small fraction of the AM signal, while inclusion of common variants from a larger genomic region appears to explain the majority of the AM signals.
Open AccessExplaining the unexplained admixture mapping signals via rare variants: the HCHS/SOL
In admixed populations, formed by a mixing of two or more previously isolated populations, genomic segments can be traced to their ancestral populations (“ancestries”). Admixture mapping (AM) associates local ancestry with outcomes in admixed populations, detecting signals when causal variants differ in frequency or effect across ancestral populations. Prior work showed that adjusting for nearby GWAS-identified common variants does not fully explain some AM signals. Here, we assessed two approaches to explain the previously unexplained AM signal: (1) including sets of rare variants; (2) increasing the genomic region considered when searching for common variants. We studied these hypotheses comprehensively using a whole-genome sequencing dataset coupled with metabolomics from the Hispanic Community Health Study/Study of Latinos. We detected multiple sets of rare variants with replicated association with metabolite levels. Yet these rare variants appear to explain only a small fraction of the AM signal, while inclusion of common variants from a larger genomic region appears to explain the majority of the AM signals.
- 1 January 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Clinical Cancer Informatics
- Vol. 10 (1) , e2500332
Web-Based User Interface for Fam3PRO: A Multigene, Multicancer Risk Prediction Model for Families With Cancer History
PURPOSE: Hereditary cancer risk is key to guiding screening and prevention strategies. Cancer risks can vary by individual because of the presence or absence of high- and moderate-risk pathogenic variants (PVs) in cancer-associated genes, in addition to sex, age, and other risk factors. We previously developed Fam3PRO, a flexible multigene, multicancer Mendelian risk prediction model that estimates a patient's risk of carrying a PV in hereditary cancer genes and their future risk of developing several types of cancers. The Fam3PRO R package includes 22 genes with 18 associated cancers, allowing users to build customized submodels from any gene-cancer set. However, the current R package lacks a user interface (UI), limiting its practical use in clinical settings. Therefore, we aim to develop a web-based UI for broader use of the Fam3PRO functionalities. METHODS: The Fam3PRO UI (F3PI), built using R Shiny, collects and formats inputs including family health history, genetic test results, and other risk factors. Pedigree data are interactively visualized and modified using pedigreejs, whereas the backend Fam3PRO model takes all the inputs to generate carrier probabilities and future cancer risks, presented through an interactive UI. RESULTS: F3PI streamlines the collection of patient and family history data, which is analyzed by the Fam3PRO models to provide personalized cancer risks for each proband across 18 cancers, as well as probabilities that a proband has a PV in up to 22 hereditary cancer genes. These results are returned to the user, within 1 minute on average, and are available in both interactive and downloadable formats. CONCLUSION: We have developed F3PI, an easy-to-use, interactive web application that makes cancer and genetic risk information more accessible to providers and their patients.
- 1 January 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Clinical Cancer Informatics
- Vol. 10 (1) , e2500332
Web-Based User Interface for Fam3PRO: A Multigene, Multicancer Risk Prediction Model for Families With Cancer History
PURPOSE: Hereditary cancer risk is key to guiding screening and prevention strategies. Cancer risks can vary by individual because of the presence or absence of high- and moderate-risk pathogenic variants (PVs) in cancer-associated genes, in addition to sex, age, and other risk factors. We previously developed Fam3PRO, a flexible multigene, multicancer Mendelian risk prediction model that estimates a patient's risk of carrying a PV in hereditary cancer genes and their future risk of developing several types of cancers. The Fam3PRO R package includes 22 genes with 18 associated cancers, allowing users to build customized submodels from any gene-cancer set. However, the current R package lacks a user interface (UI), limiting its practical use in clinical settings. Therefore, we aim to develop a web-based UI for broader use of the Fam3PRO functionalities. METHODS: The Fam3PRO UI (F3PI), built using R Shiny, collects and formats inputs including family health history, genetic test results, and other risk factors. Pedigree data are interactively visualized and modified using pedigreejs, whereas the backend Fam3PRO model takes all the inputs to generate carrier probabilities and future cancer risks, presented through an interactive UI. RESULTS: F3PI streamlines the collection of patient and family history data, which is analyzed by the Fam3PRO models to provide personalized cancer risks for each proband across 18 cancers, as well as probabilities that a proband has a PV in up to 22 hereditary cancer genes. These results are returned to the user, within 1 minute on average, and are available in both interactive and downloadable formats. CONCLUSION: We have developed F3PI, an easy-to-use, interactive web application that makes cancer and genetic risk information more accessible to providers and their patients.